Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects. - Wikidata - awgldk - TriplyDB

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

http://www.wikidata.org/entity/Q36769101

about

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension Mutational and clinical analysis of the ENG gene in patients with pulmonary arterial hypertension BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertension Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report.Decreased Endoglin expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia rat model.A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension.Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations.EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.Using omics approaches to understand pulmonary diseases.Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension.Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.The BuMPy Road to COPD Gene Discovery.A systematic review of genetic mutations in pulmonary arterial hypertension.Pulmonary arterial hypertension associated with hereditary spherocytosis and splenectomy in a patient with a mutation in the BMPR2 gene.The Role of DPO-1 and XE991-Sensitive Potassium Channels in Perivascular Adipose Tissue-Mediated Regulation of Vascular Tone.Therapeutic Potential of Smurf-1 Inhibitors for the Treatment of Pulmonary Arterial Hypertension (PAH).Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.The Long Noncoding RNA LnRPT Puts the Brakes on Pulmonary Artery Smooth Muscle Cell Proliferation.Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude.Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data.Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension

P2860

Q28067063-1EB856BE-20BA-4A99-A5BA-9543E7B29A7C Q28601711-983B3B7E-77CB-442F-9F10-CCF71384566D Q31038854-09845680-23B2-4D45-9137-F3490E63F659 Q33580827-39FA92FE-C7C4-4A13-AD5A-C666EFA3B01C Q33689573-1B9057B2-2E10-400F-BB8D-18EDF9226C72 Q33788468-4A6C684D-F15C-4853-A1D3-20D299DE8F4E Q35902174-9F9FAC09-84DC-4823-8594-B74E317F001E Q36185229-CBA3AB25-2E7D-42DC-BEEB-2DA2F08DE20B Q36340262-9FA07B03-62B8-4507-84CE-5B981A94BA46 Q36973719-84F31385-7F22-4C9B-AC5B-21CEB389F892 Q37257895-3E53C021-6B70-4AE0-8A25-9855D5CA83E2 Q37394425-3C88ACB1-C357-440A-BD11-673C8908B50F Q37555347-3DD33097-6902-41F2-9595-C350436C9197 Q37668859-40B48E9E-3CF7-4F6A-994B-9C7CCDFFF083 Q38642884-D4E8BFA8-056B-4527-B2EE-6A68E252D5EB Q38721118-86C0C526-8883-437A-B761-BBC141C8FA64 Q38779774-C903C6F5-FD61-44D9-9377-02A81A0E0C25 Q38817806-E10E0F77-74BD-4234-B056-70A033585B13 Q39003465-2748B4A4-0F0C-42DF-AF25-7FCEF6A80FBA Q39760107-4159A8D4-5796-43FC-B650-C8D2E61CE3EF Q39761905-D73F5C6F-56A5-4D59-98E3-F1184E3614D4 Q41228335-7039BE99-EFF0-43A4-AAA4-8D0C0A35F5DB Q42380076-182BE3F4-A357-4FDE-9ED9-7B768E4E1C57 Q42381681-ACB1810C-7D21-482D-876D-D09A1B1B79DB Q42382682-8A6DE505-9E27-4104-8E1C-F2FD9EC21DB0 Q47253821-D4CCDAC4-F75C-44CF-A790-3FD1345A38CF Q47726007-00CAB700-32E1-4F61-ADAA-825AB2F930F4 Q48125451-3E80BBF6-37A0-44CA-895C-20E078A4BF37 Q50261063-C8D3DF2A-135A-422F-B453-45491EEEE676 Q52590989-243A581C-06C3-4C9A-A7C5-DA677F770FEB Q54977617-C10514A7-1426-4B6E-B959-2D5C50271785 Q55008475-BD09A3D8-5274-4507-84AB-027FDB83BB25 Q55285033-2FB8ED13-E39A-4B5D-9A1C-2E8E91AC4F63 Q55286562-4CDB3C9F-C25E-4FC2-A70D-F1BCDC619965 Q58703705-BB6DFD73-1D7A-4BF1-A3D8-7BE516B57329

P2860

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

http://www.wikidata.org/entity/Q36769101

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@ast

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@en

type

label

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@ast

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@en

prefLabel

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@ast

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@en

P1433

Q36769101-A9E05FB5-4407-4B40-9EE4-1EFABE163C98

P1476

Q36769101-54365D84-9435-4FAE-9D52-21DFC191B7D1

P2093

Q36769101-0E9C9A47-BF68-4D51-8A4E-F8C2740BBE58

Q36769101-0FBDA63E-5A46-4EE0-934F-0DD78498D91F

Q36769101-1E8B71AD-D433-4B46-85D9-3CA7CF948B07

Q36769101-26625486-9BDF-4636-A857-CD002AEF5E22

Q36769101-346C518A-886B-40EA-A671-551532E91754

Q36769101-38EB4D08-9D8C-4AD8-863B-92FAA729B1A1

Q36769101-55ECF176-DC65-4E8B-8CDD-C89A5C469848

Q36769101-67F4665C-A221-4560-BE4E-26024EFA2D33

Q36769101-7B71EC07-9549-44F5-BFEC-877A013A8C8F

Q36769101-9E6F828A-20E1-4EFF-8C77-E8B56D50BE33

P2860

Q36769101-0356AA44-AA89-472B-9384-7334F3B1C527

Q36769101-071978DD-99AF-4190-9A2D-70B8F764830D

Q36769101-0859B505-8DDF-4027-990E-834FE665039D

Q36769101-0B41128D-2D12-466C-B226-C20CB460B25E

Q36769101-0E34CAA5-2F85-42D0-B083-F9EADC967461

Q36769101-19203323-515B-43F9-AF5F-4487FB5B7ECC

Q36769101-1BC17705-FBBC-4931-ADC8-8155D1DC241E

Q36769101-1BC3F142-A443-4ECE-A3BC-2A739D361B08

Q36769101-1C2031DB-56E2-435E-BE81-03E88473EEF8

Q36769101-1F796E2B-ACF6-4393-8A5A-E0FF3C82C208

P304

Q36769101-FB45B38B-DCBE-4DCB-AC82-D552BF456701

P31

Q36769101-6A719177-0190-46C9-9503-12012810A70C

P356

Q36769101-E1525876-2AB0-4597-ADA4-F99C20FB4CBB

P433

Q36769101-C5F250E4-50DC-4DA5-A6D7-F2CBAA9A5593

P478

Q36769101-990361E8-6030-48E9-BEDF-F9F94C4C223C

P50

Q36769101-0ED164C7-639C-45E0-924B-7E23C756299F

Q36769101-1E1B27B7-3491-4A1F-823B-76A6A6815A48

Q36769101-2632C49C-2DDD-453D-8F91-02D222884DF2

Q36769101-307F22D6-3F74-401C-820A-2FEA64094D4F

Q36769101-4D50F1E8-BCF4-40F6-AE62-3363736459BF

Q36769101-6F87BF61-FDA0-4A73-9015-7F4C6FFA4BB4

Q36769101-A24F2E14-1C46-4C0F-B600-7C7600A81DDC

P577

Q36769101-D7AB93DF-D683-48CC-B9E4-5447D0B76B35

P698

Q36769101-907CAFCF-0EA0-45CB-835D-9A3A5DCD1C44

P932

Q36769101-C1F17899-1B57-449D-8FD3-9A4B1AF2D521

P356

P1433

P1476

Pulmonary Arterial Hypertensio ...... ing Molecular Genetic Defects.

@en

P2093

C Gregory Elliott

http://www.w3.org/2001/XMLSchema#string

Christina A Eichstaedt

http://www.w3.org/2001/XMLSchema#string

Christine Fischer

http://www.w3.org/2001/XMLSchema#string

D Hunter Best

http://www.w3.org/2001/XMLSchema#string

Ekkehard Grünig

http://www.w3.org/2001/XMLSchema#string

Eric D Austin

http://www.w3.org/2001/XMLSchema#string

Florent Soubrier

http://www.w3.org/2001/XMLSchema#string

James E Loyd

http://www.w3.org/2001/XMLSchema#string

Katrin Hinderhofer

http://www.w3.org/2001/XMLSchema#string

Micheala A Aldred

http://www.w3.org/2001/XMLSchema#string

P2860

Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

Dynamics and interaction of caveolin-1 isoforms with BMP-receptors

Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs

Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1

Genetics and genomics of pulmonary arterial hypertension

Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

P304

1113-1127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUMU.22904

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Richard C Trembath

Laura Southgate

Nicholas W Morrell

P577

2015-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26387786

http://www.w3.org/2001/XMLSchema#string

P932

4822159

http://www.w3.org/2001/XMLSchema#string